Metabolism of indium chelates attached to monoclonal antibody

Minimal transchelation of indium from benzyl-EDTA chelate in vivo

S. V. Deshpande, R. Subramanian, M. J. McCall, S. J. DeNardo, Gerald L Denardo, C. F. Meares

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The metabolism of radiolabeled antibodies is important for radioimmunoimaging and therapy. The loss of indium-111 (111In) from the chelate can pose problems in imaging and increases the radiation dose to normal tissues. We have evaluated the loss in vivo of 111In from Lym-1-benzyl-EDTA-111In (an antibody conjugated with isothiocyanatobenzyl-EDTA) in normal mice. A monoclonal antibody (CHA 255) that binds to benzyl-EDTA-indium chelates, but not to other forms of indium, was used to measure the percent of 111In remaining in the chelate. Four days after injection, 97.4 ± 2.2% of the 111In in the liver was still in the benzyl-EDTA chelate, as was 99.4 ± 0.7% of the 111In in the urine, and 99.1 ± 0.7% of the 111In in the blood. Studies in vitro indicate that a benzyl-EDTA-111In-antibody-chelate conjugate is more stable in human serum than a benzyl-DTPA-111In conjugate, and that both benzyl-chelate conjugates are much more stable than an unsubstituted DTPA conjugate.

Original languageEnglish (US)
Pages (from-to)218-224
Number of pages7
JournalJournal of Nuclear Medicine
Volume31
Issue number2
StatePublished - 1990

Fingerprint

Indium
Monoclonal Antibodies
Antibodies
Radioimmunodetection
Pentetic Acid
Urine
Radiation
Injections
benzyl-EDTA
Liver
Serum
Therapeutics

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Metabolism of indium chelates attached to monoclonal antibody : Minimal transchelation of indium from benzyl-EDTA chelate in vivo. / Deshpande, S. V.; Subramanian, R.; McCall, M. J.; DeNardo, S. J.; Denardo, Gerald L; Meares, C. F.

In: Journal of Nuclear Medicine, Vol. 31, No. 2, 1990, p. 218-224.

Research output: Contribution to journalArticle

Deshpande, S. V. ; Subramanian, R. ; McCall, M. J. ; DeNardo, S. J. ; Denardo, Gerald L ; Meares, C. F. / Metabolism of indium chelates attached to monoclonal antibody : Minimal transchelation of indium from benzyl-EDTA chelate in vivo. In: Journal of Nuclear Medicine. 1990 ; Vol. 31, No. 2. pp. 218-224.
@article{a8c868e1c8374da3b22bfe18910686a1,
title = "Metabolism of indium chelates attached to monoclonal antibody: Minimal transchelation of indium from benzyl-EDTA chelate in vivo",
abstract = "The metabolism of radiolabeled antibodies is important for radioimmunoimaging and therapy. The loss of indium-111 (111In) from the chelate can pose problems in imaging and increases the radiation dose to normal tissues. We have evaluated the loss in vivo of 111In from Lym-1-benzyl-EDTA-111In (an antibody conjugated with isothiocyanatobenzyl-EDTA) in normal mice. A monoclonal antibody (CHA 255) that binds to benzyl-EDTA-indium chelates, but not to other forms of indium, was used to measure the percent of 111In remaining in the chelate. Four days after injection, 97.4 ± 2.2{\%} of the 111In in the liver was still in the benzyl-EDTA chelate, as was 99.4 ± 0.7{\%} of the 111In in the urine, and 99.1 ± 0.7{\%} of the 111In in the blood. Studies in vitro indicate that a benzyl-EDTA-111In-antibody-chelate conjugate is more stable in human serum than a benzyl-DTPA-111In conjugate, and that both benzyl-chelate conjugates are much more stable than an unsubstituted DTPA conjugate.",
author = "Deshpande, {S. V.} and R. Subramanian and McCall, {M. J.} and DeNardo, {S. J.} and Denardo, {Gerald L} and Meares, {C. F.}",
year = "1990",
language = "English (US)",
volume = "31",
pages = "218--224",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "2",

}

TY - JOUR

T1 - Metabolism of indium chelates attached to monoclonal antibody

T2 - Minimal transchelation of indium from benzyl-EDTA chelate in vivo

AU - Deshpande, S. V.

AU - Subramanian, R.

AU - McCall, M. J.

AU - DeNardo, S. J.

AU - Denardo, Gerald L

AU - Meares, C. F.

PY - 1990

Y1 - 1990

N2 - The metabolism of radiolabeled antibodies is important for radioimmunoimaging and therapy. The loss of indium-111 (111In) from the chelate can pose problems in imaging and increases the radiation dose to normal tissues. We have evaluated the loss in vivo of 111In from Lym-1-benzyl-EDTA-111In (an antibody conjugated with isothiocyanatobenzyl-EDTA) in normal mice. A monoclonal antibody (CHA 255) that binds to benzyl-EDTA-indium chelates, but not to other forms of indium, was used to measure the percent of 111In remaining in the chelate. Four days after injection, 97.4 ± 2.2% of the 111In in the liver was still in the benzyl-EDTA chelate, as was 99.4 ± 0.7% of the 111In in the urine, and 99.1 ± 0.7% of the 111In in the blood. Studies in vitro indicate that a benzyl-EDTA-111In-antibody-chelate conjugate is more stable in human serum than a benzyl-DTPA-111In conjugate, and that both benzyl-chelate conjugates are much more stable than an unsubstituted DTPA conjugate.

AB - The metabolism of radiolabeled antibodies is important for radioimmunoimaging and therapy. The loss of indium-111 (111In) from the chelate can pose problems in imaging and increases the radiation dose to normal tissues. We have evaluated the loss in vivo of 111In from Lym-1-benzyl-EDTA-111In (an antibody conjugated with isothiocyanatobenzyl-EDTA) in normal mice. A monoclonal antibody (CHA 255) that binds to benzyl-EDTA-indium chelates, but not to other forms of indium, was used to measure the percent of 111In remaining in the chelate. Four days after injection, 97.4 ± 2.2% of the 111In in the liver was still in the benzyl-EDTA chelate, as was 99.4 ± 0.7% of the 111In in the urine, and 99.1 ± 0.7% of the 111In in the blood. Studies in vitro indicate that a benzyl-EDTA-111In-antibody-chelate conjugate is more stable in human serum than a benzyl-DTPA-111In conjugate, and that both benzyl-chelate conjugates are much more stable than an unsubstituted DTPA conjugate.

UR - http://www.scopus.com/inward/record.url?scp=0025099617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025099617&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 218

EP - 224

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 2

ER -